share_log

Merck & Co | 8-A12B: Registration of a class of securities on a national securities exchange

Merck & Co | 8-A12B: Registration of a class of securities on a national securities exchange

默沙东 | 8-A12B：证券登记/上市
美股SEC公告 ·  05/30 16:35

Moomoo AI 已提取核心信息

Merck & Co., Inc., a pharmaceutical giant based in New Jersey, and its wholly-owned subsidiary MSD Netherlands Capital B.V., headquartered in the Netherlands, have registered a series of debt securities with the U.S. Securities and Exchange Commission (SEC). The securities include 3.250% Notes due 2032, 3.500% Notes due 2037, 3.700% Notes due 2044, and 3.750% Notes due 2054, all to be listed on the New York Stock Exchange. These debt securities are fully and unconditionally guaranteed by Merck & Co. The registration was completed on May 30, 2024, as part of the company's compliance with the Securities Exchange Act of 1934. The registration references detailed descriptions of the debt securities from the Prospectus dated May 14, 2024, and the Prospectus Supplement dated May 16, 2024. The exhibits filed with the SEC include the Indenture and Officer’s Certificates for each series of notes, confirming the formalization of the securities' terms.
Merck & Co., Inc., a pharmaceutical giant based in New Jersey, and its wholly-owned subsidiary MSD Netherlands Capital B.V., headquartered in the Netherlands, have registered a series of debt securities with the U.S. Securities and Exchange Commission (SEC). The securities include 3.250% Notes due 2032, 3.500% Notes due 2037, 3.700% Notes due 2044, and 3.750% Notes due 2054, all to be listed on the New York Stock Exchange. These debt securities are fully and unconditionally guaranteed by Merck & Co. The registration was completed on May 30, 2024, as part of the company's compliance with the Securities Exchange Act of 1934. The registration references detailed descriptions of the debt securities from the Prospectus dated May 14, 2024, and the Prospectus Supplement dated May 16, 2024. The exhibits filed with the SEC include the Indenture and Officer’s Certificates for each series of notes, confirming the formalization of the securities' terms.
总部位于新泽西州的制药巨头默沙东公司及其总部位于荷兰的全资子公司默沙东荷兰资本有限公司已向美国证券交易委员会（SEC）注册了一系列债务证券。这些证券包括2032年到期的3.250％的票据、2037年到期的3.500％的票据、2044年到期的3.700％的票据和2054年到期的3.750％的票据，全部将在纽约证券交易所上市。这些债务证券由默沙东公司全额无条件担保。作为公司遵守1934年《证券交易法》的一部分，注册于2024年5月30日完成。注册参考文件对2024年5月14日的招股说明书和2024年5月16日的招股说明书补充文件中债务证券的详细描述。向美国证券交易委员会提交的证物包括每系列票据的契约和高级管理人员证书，以确认证券条款的正式化。
总部位于新泽西州的制药巨头默沙东公司及其总部位于荷兰的全资子公司默沙东荷兰资本有限公司已向美国证券交易委员会（SEC）注册了一系列债务证券。这些证券包括2032年到期的3.250％的票据、2037年到期的3.500％的票据、2044年到期的3.700％的票据和2054年到期的3.750％的票据，全部将在纽约证券交易所上市。这些债务证券由默沙东公司全额无条件担保。作为公司遵守1934年《证券交易法》的一部分，注册于2024年5月30日完成。注册参考文件对2024年5月14日的招股说明书和2024年5月16日的招股说明书补充文件中债务证券的详细描述。向美国证券交易委员会提交的证物包括每系列票据的契约和高级管理人员证书，以确认证券条款的正式化。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间